Siemens Healthineers and Kantonsspital Baden form Long-Term Partnership for Improved Patient Care

Siemens HealthineersSiemens Healthineers and the Kantonsspital Baden (KSB) in Switzerland, a networked, regional center of competence, have formed a long-term, strategic and technological partnership for the next eight years. This "Value Partnership" includes procurement and maintenance of medical imaging systems, holistic technology management with guaranteed uptime, expansion of telemedicine solutions, technology needs and capacity assessment, process optimization, and certified employee training programs. Siemens Healthineers will also provide active support in relocating all technology to the new hospital building and commissioning it, scheduled for a start late in 2023. It will also support the expansion of the hospital’s efforts in research, for instance in mammography. KSB will be getting the latest medical technology over the next few years, helping it further enhance patient care in its region. The volume of the partnership agreement is about 44 million Swiss francs, equivalent to roughly 41 million euros.

Considered as one of the fastest-growing, most innovative healthcare providers in Switzerland, KSB wants to expand its leading strategy in transforming care delivery with technological innovations and efficient processes. “We’ve worked with Siemens Healthineers before to optimize the layout of our new imaging center and to establish process-oriented, patient-centric structures. We had such a good experience then that now we’re also relying on a strategic and technological partnership. It will enhance our ability to keep offering our patients best access to first-class care,” said Adrian Schmitter, the CEO of KSB.

Kantonsspital Baden provides treatment for more than 20,000 inpatients and almost 200,000 outpatients a year. Its Health Innovation Hub, founded in early 2018, actively advances medical and technological progress. The hospital is planned to become a worldwide reference for Value Partnerships from Siemens Healthineers.

"We see this as yet another strategically important Value Partnership in Switzerland. It will link up our strong networks, and we’ll co-manage the technology at the hospital’s sites," says Marcel Baumgartner, CEO of Siemens Healthineers Switzerland. "High-tech medical equipment is the central nervous system for future-proof healthcare delivery. Continuous training for the staff ensures that the technology will be applied the best possible ways."

This collaboration with KSB is a long-term Value Partnership. This partnership model with Siemens Healthineers enables healthcare providers to optimize business processes, expand capabilities, and advance innovation. It spans on the entire Siemens Healthineers portfolio, to generate added value above and beyond equipment itself. Value Partnerships are designed to fit the customer’s needs entirely. Siemens Healthineers has formed Value Partnerships with many healthcare providers around the world. The latest examples include Hamilton Health Sciences in Canada, the University of Missouri System in the USA, Dallah Health Company in Saudi Arabia, and Braunschweig Municipal Hospital in Germany.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Researchers Use AI to Predict Cancer Ris…

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. Pulmonary nodules appear as...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Siemens Healthineers and Penta Hospitals…

Penta Hospitals International, the largest multi-national hospital chain in Central and Eastern Europe, agreed a strategic partnership with Siemens Healthineers valued at over 30 million euros. Penta Hospitals International operates...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...